Related Experiment Video
Updated: Jun 16, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Advances in psoriasis research: From pathogenesis to therapeutics
Dineshwar Sugumaran1, Audrey Chee Hui Yong2, Johnson Stanslas1
1Pharmacotherapeutic Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia.
Abstract:
Psoriasis is a chronic inflammatory condition affecting approximately 2 % to 3 % of the global population. The pathogenesis of psoriasis is complex, involving immune dysregulation, hyperproliferation and angiogenesis. It is a multifactorial disease which is influenced by genetic and environmental factors. The development of various therapeutic agents, such as JAK inhibitors, small molecules, and biologics with potential anti-psoriatic properties was possible with the vast understanding of the pathogenesis of psoriasis. Various signalling pathways, including NF-κB, JAK-STAT, S1P, PDE-4, and A3AR that are involved in the pathogenesis of psoriasis as well as the preclinical models utilised in the research of psoriasis have been highlighted in this review. The review also focuses on technological advancements that have contributed to a better understanding of psoriasis. Then, the molecules targeting the respective signalling pathways that are still under clinical trials or recently approved as well as the latest breakthroughs in therapeutic and drug delivery approaches that can contribute to the improvement in the management of psoriasis are highlighted in this review. This review provides an extensive understanding of the current state of research in psoriasis, giving rise to opportunities for researchers to discover future therapeutic breakthroughs and personalised interventions. Efficient treatment options for individuals with psoriasis can be achieved by an extensive understanding of pathogenesis, therapeutic agents, and novel drug delivery strategies.
Insights
Psoriasis, a chronic inflammatory skin disease, involves complex immune pathways. This review highlights current research on its pathogenesis, signaling pathways, and novel therapeutic strategies for improved patient management.
Area of Science:
- Dermatology and Immunology
- Molecular Biology
- Pharmacology
Background:
- Psoriasis affects 2-3% of the global population as a chronic inflammatory skin condition.
- Its pathogenesis is multifactorial, involving immune dysregulation, hyperproliferation, angiogenesis, and genetic/environmental factors.
Purpose of the Study:
- To review the current understanding of psoriasis pathogenesis.
- To highlight advancements in therapeutic agents and drug delivery strategies.
- To identify future research opportunities for personalized interventions.
Main Methods:
- Comprehensive literature review of psoriasis pathogenesis.
- Analysis of signaling pathways (NF-κB, JAK-STAT, S1P, PDE-4, A3AR) involved in psoriasis.
- Examination of preclinical models and technological advancements in psoriasis research.
Main Results:
- Detailed overview of key signaling pathways implicated in psoriasis.
- Discussion of approved and investigational molecules targeting these pathways.
- Exploration of recent breakthroughs in therapeutic and drug delivery approaches.
Conclusions:
- An extensive understanding of psoriasis pathogenesis, signaling pathways, and therapeutic agents is crucial for developing efficient treatments.
- Technological advancements and novel drug delivery strategies offer opportunities for improved psoriasis management.
- This review provides a foundation for future research into personalized psoriasis interventions.
Related Concept Videos
iPS Cell Differentiation
EPS and iPS Cells in Disease Research
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
The JAK-STAT Signaling Pathway
Clinical Applications of Epidermal Stem Cells

